Innate Immunity Disorders in Non-Infectious Inflammatory Diseases

References

1. Hou P. Fang J. Liu Z. Shi Y. Agostini M. Bernassola F. Bove P. Candi E. Rovella V. Sica G. Sun Q. Wang Y. Scimeca M. Federici M. Mauriello A. Melino G. Macrophage polarization and metabolism in atherosclerosis. Cell. Death Dis. 2023 14 10 691 10.1038/s41419‑023‑06206‑z 37863894
   [Google Scholar]
2. Nikiforov N.G. Chegodaev Y.S. Verkhova S.S. Pudova E.A. Popov M.A. Tvorogova A.V. Zhuravlev A.D. Maslennikov R.A. Snezhkina A.V. Kudryavtseva A.V. Yegorov Y.E. Omelchenko A.V. Borodko D.D. Zybin D.I. Shumakov D.V. Orekhov A.N. Impaired LPS tolerance in monocytes of coronary atherosclerosis patients is associated with the intermediate subset. J. Leukoc Biol. 2025 117 5 qiaf060 10.1093/jleuko/qiaf060 40350260
   [Google Scholar]
3. Kotlyarov S. Role of glycolysis and nitric oxide pathway crosstalk in macrophages in atherosclerosis. Curr. Med. Chem. 2026 33 9 10.2174/0109298673339364241224102645 39865809
   [Google Scholar]
4. Wu K.K. Xu X. Wu M. Li X. Hoque M. Li G.H.Y. Lian Q. Long K. Zhou T. Piao H. Xu A. Hui H.X. Cheng K.K. MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice. Nat. Commun. 2024 15 1 8624 10.1038/s41467‑024‑53006‑w 39366973
   [Google Scholar]
5. Hu T. Liu C.H. Lei M. Zeng Q. Li L. Tang H. Zhang N. Metabolic regulation of the immune system in health and diseases: Mechanisms and interventions. Signal. Transduct. Target Ther. 2024 9 1 268 10.1038/s41392‑024‑01954‑6 39379377
   [Google Scholar]
6. Neznamov A.N. Baykova Y.P. Kubekina M.V. The role of CDKs in the regulation of the monocyte/macrophage immune response. Curr. Med. Chem. 2026 33 9 10.2174/0109298673365178250414074531 40454494
   [Google Scholar]
7. Wang J. Ji L. Gao Y. Sun J. Zhou X. Ding Y. Zhou Z. Guo X. Liu C. Wang Y. Zhang Q. Lv Z. Ma D. Inhibition of CDK5 signaling mediated inflammation in macrophages promotes cutaneous wound healing. Sci. Rep. 2025 15 1 18509 10.1038/s41598‑025‑02488‑9 40425656
   [Google Scholar]
8. Chong Y.K. Tartey S. Yoshikawa Y. Imami K. Li S. Yoshinaga M. Hirabayashi A. Liu G. Vandenbon A. Hia F. Uehata T. Mino T. Suzuki Y. Noda T. Ferrandon D. Standley D.M. Ishihama Y. Takeuchi O. Cyclin J–CDK complexes limit innate immune responses by reducing proinflammatory changes in macrophage metabolism. Sci. Signal. 2022 15 729 eabm5011 10.1126/scisignal.abm5011 35412849
   [Google Scholar]
9. Kanonykina A. Velikanova E. Markova V. Bogdanov L. Shishkova D. Shabaev A. Sinitsky M. Sinitskaya A. Poddubnyak A. Lazebnaya A. Stepanov A. Tyurina A. Lobov A. Zainullina B. Yuzhalin A. Kutikhin A. Citrullination accompanies the development of carotid atherosclerotic plaques. Curr. Med. Chem. 2026 33 9 10.2174/0109298673327175240929222308 39421992
   [Google Scholar]
10. Sokolove J. Brennan M.J. Sharpe O. Lahey L.J. Kao A.H. Krishnan E. Edmundowicz D. Lepus C.M. Wasko M.C. Robinson W.H. Brief report: Citrullination within the atherosclerotic plaque: A potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum. 2013 65 7 1719 1724 10.1002/art.37961 23553485
    [Google Scholar]
11. Knight J.S. Luo W. O’Dell A.A. Yalavarthi S. Zhao W. Subramanian V. Guo C. Grenn R.C. Thompson P.R. Eitzman D.T. Kaplan M.J. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ. Res. 2014 114 6 947 956 10.1161/CIRCRESAHA.114.303312 24425713
    [Google Scholar]